The 黑料网 FAI clinic team conducts research with human subjects in the Clinical & Translational Research Center (CTRC). The team has extensive experience in conducting oral food challenges, treating anaphylaxis, and surveying the ongoing health and well-being of our participants. Our clinical coordinators excel in providing education, reassurance, and support to all participants and families volunteering their time to our research.
Currently Enrolling
Hydrolyzed Formula in Infants and Children with Cow’s Milk Allergy
Study Overview: The purpose of this study is to qualify an extensively hydrolyzed casein-based infant formula as hypoallergenic according to the standards published by the American Academy of Pediatrics.
Who Can Participate:听Children age 3 months to 12 years with a cow’s milk allergy
Contact Information:听Lauren Herlihy | foodallergy@unc.edu
Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy
Study Overview: This clinical research study investigates the safety and tolerability of a peanut SLIT-tablet.
Who Can Participate: Part Two of Study: Ages 4-65
Contact Information: Latoya Obende | hilllr@email.unc.edu
听
Ongoing, but Closed to Enrollment
Systems Biology of Early Atopy (SUNBEAM) []
A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy []
Viaskin Peanut Immunotherapy Trial to Evaluate Safety, Simplicity, & Efficacy (VITESSE) []
Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants (OUtMATCH) []
Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy []
EPITOPE Open-label Extension Study to Evaluate the Long-term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children (EPOPEX) []
Interested in participating in a study?
Study Center Location
Questions?
Contact us at foodallergy@unc.edu
听